187 related articles for article (PubMed ID: 8935859)
1. [Mass screening for colorectal cancer].
Faivre J; Tazi MA; Launoy G
Rev Epidemiol Sante Publique; 1996; 44 Suppl 1():S7-14. PubMed ID: 8935859
[TBL] [Abstract][Full Text] [Related]
2. Screening for colorectal cancer.
Mandel JS
Curr Opin Gen Surg; 1994; ():79-84. PubMed ID: 7584018
[TBL] [Abstract][Full Text] [Related]
3. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.
Lindholm E; Brevinge H; Haglind E
Br J Surg; 2008 Aug; 95(8):1029-36. PubMed ID: 18563785
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of various screening and surveillance methods in colorectal carcinoma].
Burchert A; Schmassmann A
Schweiz Med Wochenschr; 1998 Jun; 128(25):999-1011. PubMed ID: 9691335
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).
Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P
Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368
[TBL] [Abstract][Full Text] [Related]
6. [Screening for colorectal cancer--does it help?].
Kronborg O
Nord Med; 1993; 108(10):256-8. PubMed ID: 8414943
[TBL] [Abstract][Full Text] [Related]
7. [Prevention of colorectal carcinoma. Annual hemoccult test and sigmoidoscopy every 5 years].
Rosenbaum A; Riemann JF
MMW Fortschr Med; 2000 Aug; 142(31-32):27-9. PubMed ID: 10992763
[TBL] [Abstract][Full Text] [Related]
8. Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study.
Faivre J; Tazi MA; El Mrini T; Lejeune C; Benhamiche AM; Dassonville F
Br J Cancer; 1999 Feb; 79(3-4):680-3. PubMed ID: 10027349
[TBL] [Abstract][Full Text] [Related]
9. Screening for rectal cancer.
St John DJ
Hepatogastroenterology; 2000; 47(32):305-9. PubMed ID: 10791177
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiology and screening of colorectal cancer].
Dancourt V; Faivre J
Rev Prat; 2004 Jan; 54(2):135-42. PubMed ID: 15086055
[TBL] [Abstract][Full Text] [Related]
12. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.
Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Church T; Yurgalevitch S; Austin JH; Prorok PC; Gohagan JK;
J Natl Cancer Inst; 2005 Jul; 97(13):989-97. PubMed ID: 15998952
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening.
Berry DP; Clarke P; Hardcastle JD; Vellacott KD
Br J Surg; 1997 Sep; 84(9):1274-6. PubMed ID: 9313712
[TBL] [Abstract][Full Text] [Related]
14. [Randomized controlled trial of sequence mass screening program for colorectal cancer].
Liu X; Zheng S; Chen K; Ma X; Zhou L; Yu H; Yao K; Chen K; Cai S; Zhang S
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):430-3. PubMed ID: 11860828
[TBL] [Abstract][Full Text] [Related]
15. [Evidence-based planning: the case of mass screening for colorectal cancer in the Lazio region of Italy].
Federici A; Borgia P; Guasticchi G
Ann Ig; 2005; 17(4):313-22. PubMed ID: 16156391
[TBL] [Abstract][Full Text] [Related]
16. Limitations of the faecal occult blood test in screening for colorectal cancer.
Delcò F; Sonnenberg A
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
18. Is it reasonable to use faecal occult blood test for colorectal cancer screening?
Musil D; Tillich J
Acta Univ Palacki Olomuc Fac Med; 1999; 142():119-21. PubMed ID: 10743740
[TBL] [Abstract][Full Text] [Related]
19. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
Levin B; Hess K; Johnson C
Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
[TBL] [Abstract][Full Text] [Related]
20. [Cost of a mass screening program for colorectal cancer using the occult blood test].
Arveux P; Faivre J; Bedenne L; Durand G; Milan C; Milan C
Gastroenterol Clin Biol; 1992; 16(6-7):547-51. PubMed ID: 1526416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
